SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form S-1/A - General form for registration of securities under the Securities Act of 1933: [Amend]
SEC Accession No. 0001193125-24-152294
Filing Date
2024-06-03
Accepted
2024-06-03 06:08:33
Documents
29

Document Format Files

Seq Description Document Type Size
1 S-1/A d803738ds1a.htm S-1/A 2654455
2 EX-1.1 d803738dex11.htm EX-1.1 210961
3 EX-3.1 d803738dex31.htm EX-3.1 132283
4 EX-3.2 d803738dex32.htm EX-3.2 29549
5 EX-3.4 d803738dex34.htm EX-3.4 121913
6 EX-5.1 d803738dex51.htm EX-5.1 5048
7 EX-10.2 d803738dex102.htm EX-10.2 218139
8 EX-10.3 d803738dex103.htm EX-10.3 45003
9 EX-10.4 d803738dex104.htm EX-10.4 153543
10 EX-10.5 d803738dex105.htm EX-10.5 13000
11 EX-10.6 d803738dex106.htm EX-10.6 12775
12 EX-10.7 d803738dex107.htm EX-10.7 65614
13 EX-10.8 d803738dex108.htm EX-10.8 63084
14 EX-10.9 d803738dex109.htm EX-10.9 63799
15 EX-23.1 d803738dex231.htm EX-23.1 1875
16 EX-FILING FEES d803738dexfilingfees.htm EX-FILING FEES 24166
17 GRAPHIC g803738g00m02.jpg GRAPHIC 41235
18 GRAPHIC g803738g00m26.jpg GRAPHIC 131536
19 GRAPHIC g803738g00m27.jpg GRAPHIC 137274
20 GRAPHIC g803738g00m29.jpg GRAPHIC 96411
21 GRAPHIC g803738g00m30.jpg GRAPHIC 110968
22 GRAPHIC g803738g00m31.jpg GRAPHIC 107683
23 GRAPHIC g803738g00m33.jpg GRAPHIC 114611
24 GRAPHIC g803738g25c41.jpg GRAPHIC 200531
25 GRAPHIC g803738g35h11.jpg GRAPHIC 144342
26 GRAPHIC g803738g41i38.jpg GRAPHIC 80014
27 GRAPHIC g803738g56a01.jpg GRAPHIC 81756
28 GRAPHIC g803738g76c15.jpg GRAPHIC 81101
29 GRAPHIC g803738g91o98.jpg GRAPHIC 124443
  Complete submission text file 0001193125-24-152294.txt   5774902
Mailing Address 1325 BOYLSTON STREET SUITE 401 BOSTON MA 02215
Business Address 1325 BOYLSTON STREET SUITE 401 BOSTON MA 02215 857-321-8020
Rapport Therapeutics, Inc. (Filer) CIK: 0002012593 (see all company filings)

IRS No.: 880724208 | State of Incorp.: DE | Fiscal Year End: 1231
Type: S-1/A | Act: 33 | File No.: 333-279486 | Film No.: 241011898
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)